CBD Conditions - Irritable Bowel Syndrome
Irritable Bowel Syndrome (IBS) is a digestive disorder in which abdominal pain is associated with a variety of symptoms. IBS affects between 25 and 45 million Americans and affects more women than men. There is no cure for IBS but living with the chronic pain associated with it is manageable but there are few treatments. It can affect anyone, at any age and there is no exact cause for it. Researchers have found that there is a connection between the brain and the gut and that triggers can worsen it.
- Cannabidiol in inflammatory bowel diseases: A brief overview
- CBD reduces intestinal inflammation through the control of neuroimmune axis
- Clinical endocannabinoid deficiency (CECD): Can this concept explain therapeutic benefits of cannabis in migraine, fibromyalgia, irritable bowel syndrome and other treatment-resistant conditions?
- Cannabinoid actions at TRPV channels: Effects on TRPV3 and TRPV4 and their potential relevance to gastrointestinal inflammation
- Therapeutic potential of cannabinoid-based drugs
- Beneficial effect of the non-psychotropic plant cannabinoid cannabigerol on experimental inflammatory bowel disease (Biochemical Pharmacology)
- CBD and the gut: New developments and emerging concepts
- Endocannabinoids and the gastrointestinal tract
- CBD and gastrointestinal motility
- Getting into the weed: the role of the endocannabinoid system in the brain-gut axis
- Cannabinoids and GI Disorders: Endogenous and Exogenous